Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006657887> ?p ?o ?g. }
- W2006657887 endingPage "492.e7" @default.
- W2006657887 startingPage "481" @default.
- W2006657887 abstract "Background & AimsSustained activation of the cytosolic calcium concentration induces injury to pancreatic acinar cells and necrosis. The calcium release–activated calcium modulator ORAI1 is the most abundant Ca2+ entry channel in pancreatic acinar cells; it sustains calcium overload in mice exposed to toxins that induce pancreatitis. We investigated the roles of ORAI1 in pancreatic acinar cell injury and the development of acute pancreatitis in mice.MethodsMouse and human acinar cells, as well as HEK 293 cells transfected to express human ORAI1 with human stromal interaction molecule 1, were hyperstimulated or incubated with human bile acid, thapsigargin, or cyclopiazonic acid to induce calcium entry. GSK-7975A or CM_128 were added to some cells, which were analyzed by confocal and video microscopy and patch clamp recordings. Acute pancreatitis was induced in C57BL/6J mice by ductal injection of taurolithocholic acid 3-sulfate or intravenous' administration of cerulein or ethanol and palmitoleic acid. Some mice then were given GSK-7975A or CM_128, which inhibit ORAI1, at different time points to assess local and systemic effects.ResultsGSK-7975A and CM_128 each separately inhibited toxin-induced activation of ORAI1 and/or activation of Ca2+ currents after Ca2+ release, in a concentration-dependent manner, in mouse and human pancreatic acinar cells (inhibition >90% of the levels observed in control cells). The ORAI1 inhibitors also prevented activation of the necrotic cell death pathway in mouse and human pancreatic acinar cells. GSK-7975A and CM_128 each inhibited all local and systemic features of acute pancreatitis in all 3 models, in dose- and time-dependent manners. The agents were significantly more effective, in a range of parameters, when given at 1 vs 6 hours after induction of pancreatitis.ConclusionsCytosolic calcium overload, mediated via ORAI1, contributes to the pathogenesis of acute pancreatitis. ORAI1 inhibitors might be developed for the treatment of patients with pancreatitis. Sustained activation of the cytosolic calcium concentration induces injury to pancreatic acinar cells and necrosis. The calcium release–activated calcium modulator ORAI1 is the most abundant Ca2+ entry channel in pancreatic acinar cells; it sustains calcium overload in mice exposed to toxins that induce pancreatitis. We investigated the roles of ORAI1 in pancreatic acinar cell injury and the development of acute pancreatitis in mice. Mouse and human acinar cells, as well as HEK 293 cells transfected to express human ORAI1 with human stromal interaction molecule 1, were hyperstimulated or incubated with human bile acid, thapsigargin, or cyclopiazonic acid to induce calcium entry. GSK-7975A or CM_128 were added to some cells, which were analyzed by confocal and video microscopy and patch clamp recordings. Acute pancreatitis was induced in C57BL/6J mice by ductal injection of taurolithocholic acid 3-sulfate or intravenous' administration of cerulein or ethanol and palmitoleic acid. Some mice then were given GSK-7975A or CM_128, which inhibit ORAI1, at different time points to assess local and systemic effects. GSK-7975A and CM_128 each separately inhibited toxin-induced activation of ORAI1 and/or activation of Ca2+ currents after Ca2+ release, in a concentration-dependent manner, in mouse and human pancreatic acinar cells (inhibition >90% of the levels observed in control cells). The ORAI1 inhibitors also prevented activation of the necrotic cell death pathway in mouse and human pancreatic acinar cells. GSK-7975A and CM_128 each inhibited all local and systemic features of acute pancreatitis in all 3 models, in dose- and time-dependent manners. The agents were significantly more effective, in a range of parameters, when given at 1 vs 6 hours after induction of pancreatitis. Cytosolic calcium overload, mediated via ORAI1, contributes to the pathogenesis of acute pancreatitis. ORAI1 inhibitors might be developed for the treatment of patients with pancreatitis." @default.
- W2006657887 created "2016-06-24" @default.
- W2006657887 creator A5008683089 @default.
- W2006657887 creator A5017204235 @default.
- W2006657887 creator A5024617116 @default.
- W2006657887 creator A5026698817 @default.
- W2006657887 creator A5027345957 @default.
- W2006657887 creator A5032999963 @default.
- W2006657887 creator A5034193600 @default.
- W2006657887 creator A5038317412 @default.
- W2006657887 creator A5044695907 @default.
- W2006657887 creator A5056676664 @default.
- W2006657887 creator A5056960364 @default.
- W2006657887 creator A5059820643 @default.
- W2006657887 creator A5064285618 @default.
- W2006657887 creator A5067942048 @default.
- W2006657887 creator A5072338475 @default.
- W2006657887 creator A5072425437 @default.
- W2006657887 creator A5072647961 @default.
- W2006657887 creator A5077413029 @default.
- W2006657887 creator A5079841235 @default.
- W2006657887 creator A5085336371 @default.
- W2006657887 creator A5087909247 @default.
- W2006657887 creator A5087974283 @default.
- W2006657887 date "2015-08-01" @default.
- W2006657887 modified "2023-10-16" @default.
- W2006657887 title "Inhibitors of ORAI1 Prevent Cytosolic Calcium-Associated Injury of Human Pancreatic Acinar Cells and Acute Pancreatitis in 3 Mouse Models" @default.
- W2006657887 cites W1847229375 @default.
- W2006657887 cites W1966051958 @default.
- W2006657887 cites W1976211445 @default.
- W2006657887 cites W1980948951 @default.
- W2006657887 cites W1985045980 @default.
- W2006657887 cites W2000755489 @default.
- W2006657887 cites W2006590632 @default.
- W2006657887 cites W2011400811 @default.
- W2006657887 cites W2015080011 @default.
- W2006657887 cites W2041233801 @default.
- W2006657887 cites W2043519102 @default.
- W2006657887 cites W2044563193 @default.
- W2006657887 cites W2049075282 @default.
- W2006657887 cites W2056467210 @default.
- W2006657887 cites W2067406751 @default.
- W2006657887 cites W2072943291 @default.
- W2006657887 cites W2075035705 @default.
- W2006657887 cites W2076362618 @default.
- W2006657887 cites W2122310415 @default.
- W2006657887 cites W2128489958 @default.
- W2006657887 cites W2128677222 @default.
- W2006657887 cites W2130362571 @default.
- W2006657887 cites W2132814418 @default.
- W2006657887 cites W2143057135 @default.
- W2006657887 cites W2143566210 @default.
- W2006657887 cites W2145758369 @default.
- W2006657887 cites W2154564976 @default.
- W2006657887 cites W2168026341 @default.
- W2006657887 cites W2171165037 @default.
- W2006657887 cites W2318489156 @default.
- W2006657887 cites W2744105079 @default.
- W2006657887 cites W4211022384 @default.
- W2006657887 cites W77248263 @default.
- W2006657887 doi "https://doi.org/10.1053/j.gastro.2015.04.015" @default.
- W2006657887 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4556985" @default.
- W2006657887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25917787" @default.
- W2006657887 hasPublicationYear "2015" @default.
- W2006657887 type Work @default.
- W2006657887 sameAs 2006657887 @default.
- W2006657887 citedByCount "147" @default.
- W2006657887 countsByYear W20066578872015 @default.
- W2006657887 countsByYear W20066578872016 @default.
- W2006657887 countsByYear W20066578872017 @default.
- W2006657887 countsByYear W20066578872018 @default.
- W2006657887 countsByYear W20066578872019 @default.
- W2006657887 countsByYear W20066578872020 @default.
- W2006657887 countsByYear W20066578872021 @default.
- W2006657887 countsByYear W20066578872022 @default.
- W2006657887 countsByYear W20066578872023 @default.
- W2006657887 crossrefType "journal-article" @default.
- W2006657887 hasAuthorship W2006657887A5008683089 @default.
- W2006657887 hasAuthorship W2006657887A5017204235 @default.
- W2006657887 hasAuthorship W2006657887A5024617116 @default.
- W2006657887 hasAuthorship W2006657887A5026698817 @default.
- W2006657887 hasAuthorship W2006657887A5027345957 @default.
- W2006657887 hasAuthorship W2006657887A5032999963 @default.
- W2006657887 hasAuthorship W2006657887A5034193600 @default.
- W2006657887 hasAuthorship W2006657887A5038317412 @default.
- W2006657887 hasAuthorship W2006657887A5044695907 @default.
- W2006657887 hasAuthorship W2006657887A5056676664 @default.
- W2006657887 hasAuthorship W2006657887A5056960364 @default.
- W2006657887 hasAuthorship W2006657887A5059820643 @default.
- W2006657887 hasAuthorship W2006657887A5064285618 @default.
- W2006657887 hasAuthorship W2006657887A5067942048 @default.
- W2006657887 hasAuthorship W2006657887A5072338475 @default.
- W2006657887 hasAuthorship W2006657887A5072425437 @default.
- W2006657887 hasAuthorship W2006657887A5072647961 @default.
- W2006657887 hasAuthorship W2006657887A5077413029 @default.
- W2006657887 hasAuthorship W2006657887A5079841235 @default.
- W2006657887 hasAuthorship W2006657887A5085336371 @default.
- W2006657887 hasAuthorship W2006657887A5087909247 @default.